![Graham Parry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Graham Parry
Chief Tech/Sci/R&D Officer at
ELECTRA THERAPEUTICS, INC.
Net worth: 961 920 $ as of 2026-09-29
Profile
Dr. Graham Parry is a Chief Scientific Officer at Electra Therapeutics, Inc. Dr. Parry was previously employed as an Executive Vice President-Translational Sciences by Star Therapeutics, Inc., a Senior Vice President-Translational Sciences by Third Harmonic Bio, Inc., a Vice President-Technical Operations by True North Therapeutics, Inc., a Biology Director by Attenuon, LLC, and a Principal by Motility, Inc. He received his undergraduate degree from Brunel University London and a doctorate degree from the University of London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-20 | 85,504 ( 0.14% ) | 961 920 $ | 2026-09-29 |
Graham Parry active positions
| Companies | Position | Start |
|---|---|---|
| ELECTRA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-11-30 |
Former positions of Graham Parry
| Companies | Position | End |
|---|---|---|
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Corporate Officer/Principal | 2023-11-30 |
| THIRD HARMONIC BIO, INC. | Corporate Officer/Principal | 2022-11-30 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Chief Tech/Sci/R&D Officer | 2016-12-31 |
Motility, Inc. | Corporate Officer/Principal | - |
Attenuon, LLC
 Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Corporate Officer/Principal | - |
Education of Graham Parry
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
21
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Brunel University
 Brunel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Attenuon, LLC
Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Motility, Inc. | |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases & disorders | Health Technology |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological and cancer diseases | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Health Technology |
- Stock Market
- Insiders
- Graham Parry
